Nvidia has agreed to acquire Hugging Face, the open-source AI model hub used by millions of developers, for roughly $12.93 billion, extending its control deeper into the AI stack beyond chips. The deal faces antitrust scrutiny over whether Nvidia could use the platform to disadvantage rival hardware makers like AMD and Intel.
Alibaba unveiled the Zhenwu V900, a homegrown AI chip it calls China's most powerful, alongside a plan to grow Alibaba Cloud's global data center capacity to 20 gigawatts by 2032. The announcement highlights both China's push for chip self-reliance amid U.S. export curbs and the broader global race to build out AI infrastructure.
Novo Nordisk is embedding Anthropic's Claude models across its drug discovery operations as it races to keep pace with Eli Lilly in the obesity-drug market. The deal is part of a broader 2026 wave of pharma-AI tie-ups, though skeptics note none has yet produced an approved drug credited to the technology.
Hamamatsu Photonics won FDA 510(k) clearance on September 2, 2026 for two NanoZoomer whole-slide imaging scanners for primary diagnostic use, breaking Leica Biosystems' near-lock on cleared digital pathology scanning hardware that AI diagnostic tools depend on.
Ergomotion launched its free AI-powered Sleep Assist app on August 1, 2026, turning its RIO Eco smart adjustable beds into contactless sleep monitors with an AI assistant that answers plain-language questions about a user's own nightly sleep data.
Google and Singapore microbiome firm AMILI launched AMILI Optimise in April 2026, an eight-week AI-driven nutrition program that combines meal photos, continuous glucose monitoring, and fecal sample sequencing to generate personalized dietary recommendations based on gut microbiome data.
A federal court consolidated class actions against Tempus AI on April 15, 2026, alleging the company disclosed patients' genetic data, gathered through its $600 million Ambry Genetics acquisition, to pharmaceutical partners in deals worth $1.1 billion without written consent.
Whoop rolled out AI features called My Memory and Proactive Check-Ins alongside a new fee-based, on-demand video consultation service with licensed clinicians and an EHR-syncing partnership with HealthEx, pushing the wearable maker further from fitness tracking and toward clinical care.
The FDA has granted 510(k) clearance to iHealthScreen's iPredict-DR, an AI screening tool paired with the iCare DRSplus fundus camera that lets primary care staff detect diabetic retinopathy without an ophthalmologist on site.
Ultrahuman raised a $70 million round led by Qualcomm Ventures on September 3, 2026, valuing the Indian wearables startup at $365 million as it works with Qualcomm on a future ring that runs on-device AI rather than just tracking sleep and recovery.